Delayed increase in LDL cholesterol following pentagastrin-induced panic attacks

Psychopharmacology

Volumn 193, Issue 3, 2007, Pages 333-340

  Perez Parada, Jorge ^a   Jhangri, Gian S ^b   Lara, Nathalie ^a   Chrapko, Wendy ^a   Castillo Abadia, Maria Del Pilar ^a   Gil, Lucas ^a   Le Mellédo, Jean Michel ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardiovascular; Cholecystokinin; Cholesterol; LDL; Panic disorder

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; PENTAGASTRIN; PLACEBO;

ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; PANIC; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PANIC DISORDER; PENTAGASTRIN;

EID: 34447338356     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0759-2     Document Type: Article

References (40)

1. Abelson JL, Nesse RM (1994) Pentagastrin infusions in patients with panic disorder I. Symptoms and cardiovascular response. Biol Psychiatry 36:73-83
2. Abelson JL, Liberzon I, Young EA, Khan S (2005) Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects. Arch Gen Psychiatry 62:668-675
3. Agargun MY, Kara H, Algun E, Sekeroglu R, Trakcioglu M (1996) High cholesterol levels in patients with sleep panic. Biol Psychiatry 40:1064-1065
4. Bachen EA, Muldoon MF, Matthews KA, Manuck SB (2002) Effects of hemoconcentration and sympathetic activation on serum lipid responses to brief mental stress. Psychosom Med 64:587-594
5. Bajwa WK, Asnis GM, Sanderson WC, Irfan A, van Pragg HM (1992) High cholesterol levels in patients with panic disorder. Am J Psychiatry 149:376-378
6. Barnett JB, Woods MN, Lamon-Fava S, Schaefer EJ, McNamara JR, Spiegelman D, Hertzmark E, Goldin B, Longcope C, Gorbach SL (2004) Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle. J Clin Endocrinol Metab 89:776-782
7. Bradwejn J, Koszycki D, Shriqui C (1991) Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder; clinical and behavioral findings. Arch Gen Psychiatry 48:603-610
8. Coryell W, Noyes R, Clancy J (1982) Excess mortality in panic disorder. Arch Gen Psychiatry 39:701-703
9. Coryell W, Noyes R, House D (1986) Mortality among outpatients with anxiety disorders. Am J Psychiatry 143:508-510
10. Dakak N, Quyyumi AA, Eisenhofer G, Goldstein DS, Cannon RO (1995) Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. Am J Cardiol 76:125-130
11. Fleet R, Lavoie K, Beitman BD (2000) Is panic disorder associated with coronary artery disease? A critical review of the literature. J Psychosom Res 48:347-356
12. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
13. Gaziano MJ, Manson JE, Ridker PM (2005) Primary and secondary prevention of coronary heart disease. In: Zipes DP, Libby P, Bonow RO, Braunwald E (eds) Braunwald's heart disease: a textbook of cardiovascular medicine. Saunders, Philadelphia, PA, p 1068
14. Grundy SM, Cleeman JI, Merz CNB, Brewer HB, Clar LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ (2004) Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 110:227-239
15. Haines AP, Imeson JD, Meade TW (1987) Phobic anxiety and ischaemic heart disease. BMJ 295:297-299
16. Hayward C, Taylor CB, Roth WT, King R, Agras WS (1989) Plasma lipid levels in patients with panic disorder or agoraphobia. Am J Psychiatry 146:917-919
17. Herd JA (1983) Physiological basis for behavioral influences in arteriosclerosis. In: Dembroski TM, Schmidt TH, Blumchen G (eds) Biobehavioural basis of coronary heart disease. Karger, Basel, pp 248-256
18. Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willett WC (1994) Coronary heart disease/myocardial infarction: prospective study of phobic anxiety and the risk of coronary heart disease in men. Circulation 89:1992-1997
19. Khan S, Liberzon I, Abelson JL (2004) Effects of propranolol on symptom and endocrine responses to pentagastrin. Psychoneuroendocrinology 29:1163-1171
20. Krantz DS, Kop WJ, Santiago HT, Gottdiener JS (1996) Mental stress as a trigger of myocardial ischemia and infarction. Cardiol Clin 14:271-287
21. Lara N, Baker GB, Archer SL, Le Mellédo JM (2003) Increased cholesterol levels during paroxetine administration in healthy men. J Clin Psychiatry 64:1455-1459
22. LeMellédo J-M, Bradwejn J, Koszycki D, Bichet DG, Bellavance F (1998) The role of the β-noradrenergic system in cholecystokinin- tetrapeptide-induced panic symptoms. Biol Psychiatry 44:364-366
23. Liebowitz MR, Gelenberg AJ, Munjack D (2005a) Venlafaxine extended release vs. placebo and paroxetine in social anxiety disorder. Arch Gen Psychiatry 65:190-198
24. Liebowitz MR, Mangano RM, Bradwejn J, Asnis G (2005b) A randomized controlled trial of venlafazine extended release in generalized anxiety disorder. J Clin Psychiatry 66:238-247
25. McCann BS, Carter J, Vaughan M, Raskind M, Wilkinson CW, Veith RC (1993) Cardiovascular and neuroendocrine responses to extended laboratory challenge. Psychosom Med 55:497-504
26. McCann BS, Magee MS, Broyles FC, Vaughan M, Alber JJ, Knopp RH (1995) Acute psychological stress and epinephrine infusion in normolipidemic and hyperlipidemic men: effects on plasma lipid and apoprotein concentrations. Psychosom Med 57:165-176
27. Morrow JD, McManus K, Tait GR, Bellavance F, Chrapko W, Lara N, Le Mellédo J-M (2003) Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol. J Psychiatry Neurosci 28:127-133
28. Muldoon MF, Herbert TB, Patterson SM, Kameneva M, Raible R, Manuck SB (1992) Acute cholesterol responses to mental stress and change in posture. Arch Intern Med 152:775-780
29. Muldoon MF, Bachen EA, Manuck SB, Waldstein SR, Bricker PL, Bennett JA (1995) Effects of acute psychological stress on serum lipid levels, hemoconcentration and blood viscosity. Arch Intern Med 155:615-620
30. Patterson SM, Gottdiener JS, Hecht G, Vargot S, Krant DS (1993) Effects of acute psychological stress on serum lipids: mediating effects of plasma volume. Psychosom Med 55:525-532
31. Peter H, Hand I, Hohagen F, Koenig A, Mindermann O, Oeder F, Wittich M (2002) Serum cholesterol level comparison: control subjects, anxiety disorder patients, and obsessive compulsive disorder patients. Can J Psychiatry 47:557-561
32. Rickels K, Mangano R, Khan A (2004) A double blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder. J Clin Psychopharmacol 24:488-496
33. Schneiderman N (1983) Behavior, autonomic function and animal models of cardiovascular pathology. In: Dembroski TM, Schmidt TH, Blumchen G (eds) Biobehavioural basis of coronary heart disease. Karger, Basel, pp 304-364
34. Shioiri T, Fujii K, Someya T, Takahashi S (2000) Serum cholesterol levels and panic symptoms in patients with panic disorder: a preliminary study. J Affect Disord 58:167-170
35. Steiner G, Poapst ME, Shumak SL, Foster DM (1986) Metabolism of apolipoprotein B-containing lipoproteins. Methods Enzymol 129:395-440
36. Tancer ME, Stein MB, Moul DE, Uhde TU (1990) Normal serum cholesterol in panic disorder. Biol Psychiatry 27:99-101
37. Van Megen HJ, Westenberg HG, den Boer JA, Haigh JR, Traub M (1994) Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients. Psychopharmacology 114:449-455
38. Van Megen HJ, Westenberg HG, den Boer JA, Kahn RS (1996) Cholecystokinin in anxiety. Eur Neuropsychopharmacol 6:263-280
39. Weissman MM, Markowitz JS, Ouellette R, Greenwald S, Kahn JP (1990) Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry 147:1504-1508
40. Yeragani VK, Balon R, Pohl R, Ramesh C, Glitz D, Weinberg P, Merlos B (1990) Decreased R-R variance in panic disorder patients. Acta Psychiatr Scand 81:554-559